Antibiotic | Antibiotic susceptibilitya(%) | |||
---|---|---|---|---|
E. coli | All Gram - | All Gram + | All pathogens | |
(n = 157) | (n = 178) | (n = 25) | (n = 203) | |
Amoxicillin | 63 | 56 | 32 | / |
Amox/clav | 91 | 88 | NTb | / |
Ticarcillin | 64 | 61 | NT | / |
Ticar/clav | 92 | 92 | NT | / |
Piperacillin | 64 | 61 | NT | / |
Pip/Taz | 99 | 99 | NT | / |
Pivmecillinam | 87 | 88 | NT | 76c |
Cefalotin | 63 | 61 | NT | / |
Cefotaxime | 99 | 99 | NT | / |
Ceftazidime | 99 | 99 | NT | / |
Cefepime | 99 | 99 | NT | / |
Imipenem/cilastatin | 100 | 100 | NT | / |
Gentamicin | 99 | 99 | 57d | / |
Tobramycin | 99 | 99 | NT | / |
Amikacin | 100 | 100 | NT | / |
Netilmicin | 99 | 99 | NT | / |
TMP-SMX | 87 | 87 | 63 | 85 |
Nalidix acid | 97 | 87 | NT | / |
Ofloxacin | 97 | 99 | 59 | 94 |
Levofloxacin | 97 | 99 | 95 | 98 |
Nitrofurantoin | 100 | 92e | 100 | 98 |
Fosfomycin | 99 | 98 | 27 | 89 |
Fucidic acid | NT | NT | 58 | / |
Erythromycin | NT | NT | 17 | / |
Lincomycin | NT | NT | 62 | / |
Pristinamycin | NT | NT | 62 | / |
Rifampin | NT | NT | 61 | / |
Vancomycin | NT | NT | 100 | / |